Veterans are at an increased risk for Alzheimer’s disease. The goal of the BRAVE study is to find out if a prescription strength dose of fish oil can stop or delay early brain changes associated with Alzheimer’s disease.
The BRAVE study is no longer recruiting participants.
Final results will be posted at ClinicalTrials.gov. As all registered trials are required to post results to this website, this is the best public source for study results.
About Vascepa
Learn more about Vascepa, the prescription fish oil being used for this study.
The BRAVE study in the news
"Researching the Impact Fish Oil on Alzheimer’s Disease and Veterans: The Sacrifice May Not End with Military Service"
The Capital City Hues, April 22, 2019
"VA study looks at effect of fish oil on Alzheimer's"
Lake Mills Leader, December 19, 2018
"VA Study Looks at Effect of Fish Oil on Alzheimer's Disease Risk in Veteran Population"
Post Messenger Record, December 6, 2018
"UW, VA study looks at fish oil to prevent Alzheimer's disease"
Wisconsin State Journal, December 9, 2017
"VA Study - Alzheimer's Disease Risk in Veterans" (see page 12)
VFW Wisconsin, July/August 2017
"Brave Study looks at veterans and Alzheimer's disease"
WISC-TV News 3, November 15, 2017